The MUC16-mesothelin interaction is capable of activating MUC16, thus enhancing ovarian cancer cell metastasis and the epithelial mesothelial to mesenchymal transition, suggesting that the binding of these proteins triggers pathways that regulate cellular adhesion and motility [42]. Here, MSLN is linked to ovarian cancer.